BIMATOPROST

BIMATOPROST was reported 28889 times

BIMATOPROST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROSTAGLANDIN ANALOGUE PERIORBITOPATHY 12 0.6667
1 BLEPHAROPACHYNSIS 20 0.6452
2 BLEPHARAL PIGMENTATION 279 0.5525
3 PERIORBITAL FAT ATROPHY 23 0.5349
4 EYELASH HYPERPIGMENTATION 24 0.4800
5 IRIS HYPERPIGMENTATION 99 0.4760
6 GROWTH OF EYELASHES 299 0.3775
7 EYELASH CHANGES 65 0.3672
8 EYELID VASCULAR DISORDER 9 0.3462
9 EYELASH DISCOLOURATION 56 0.2557
10 CORNEAL ENDOTHELIAL CELL LOSS 15 0.2206
11 EYELASH THICKENING 25 0.2083
12 SCLERAL HYPERAEMIA 134 0.1968
13 IRIS DISCOLOURATION 9 0.1957
14 ERYTHEMA OF EYELID 1015 0.1873
15 EYELASH INJURY 9 0.1800
16 ENOPHTHALMOS 18 0.1782
17 LID SULCUS DEEPENED 66 0.1769
18 TRICHIASIS 55 0.1730
19 EYELIDS PRURITUS 531 0.1702
20 EYELID SENSORY DISORDER 31 0.1574
21 EYELID THICKENING 44 0.1544
22 EYELID IRRITATION 378 0.1505
23 MADAROSIS 1395 0.1201
24 EYELID EXFOLIATION 91 0.1152
25 INTRAOCULAR PRESSURE FLUCTUATION 22 0.1117
26 TRABECULECTOMY 10 0.1087
27 SCLERAL PIGMENTATION 10 0.1053
28 TRICHORRHEXIS 281 0.1006
29 CONJUNCTIVAL SCAR 12 0.0795
30 IRIS DISORDER 40 0.0743
31 EYELID PAIN 148 0.0728
32 IMPLANTATION COMPLICATION 15 0.0721
33 EYE COLOUR CHANGE 72 0.0707
34 OCULAR SURFACE DISEASE 18 0.0641
35 INTRAOCULAR PRESSURE DECREASED 33 0.0626
36 CORNEAL DECOMPENSATION 10 0.0621
37 EYELID RASH 60 0.0613
38 DERMATOCHALASIS 9 0.0612
39 INTRAOCULAR PRESSURE INCREASED 731 0.0571
40 SKIN HYPERPIGMENTATION 482 0.0560
41 DARK CIRCLES UNDER EYES 79 0.0537
42 PERIORBITAL DISORDER 11 0.0537
43 EYELID SKIN DRYNESS 64 0.0528
44 EYE REDNESS 14 0.0500
45 OCULAR HYPERAEMIA 2364 0.0498
46 OPEN ANGLE GLAUCOMA 29 0.0472
47 GLAUCOMA SURGERY 12 0.0469
48 INTRAOCULAR PRESSURE TEST ABNORMAL 33 0.0468
49 PRODUCT DROPPER ISSUE 36 0.0457
50 LENTIGO MALIGNA 12 0.0448
51 EYELID CYST 11 0.0425
52 EYE COMPLICATION ASSOCIATED WITH DEVICE 11 0.0409
53 EYE PRURITUS 1341 0.0399
54 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 9 0.0395
55 REACTION TO PRESERVATIVES 32 0.0393
56 TREATMENT FAILURE 3083 0.0372
57 SCLERAL DISCOLOURATION 24 0.0366
58 EYELID OEDEMA 419 0.0360
59 MILIA 13 0.0358
60 BLEPHARITIS 142 0.0354
61 FOREIGN BODY SENSATION IN EYES 216 0.0339
62 EYE IRRITATION 1882 0.0327
63 CORNEAL OEDEMA 73 0.0325
64 CHOROIDAL DETACHMENT 18 0.0324
65 CORNEAL INFILTRATES 10 0.0318
66 EYELID DISORDER 73 0.0316
67 EYELID MARGIN CRUSTING 90 0.0311
68 FAT TISSUE DECREASED 12 0.0308
69 EYE DISCHARGE 307 0.0295
70 CORNEAL OPACITY 38 0.0278
71 HAIR GROWTH ABNORMAL 188 0.0271
72 ABNORMAL SENSATION IN EYE 111 0.0258
73 SWELLING OF EYELID 160 0.0255
74 CHALAZION 16 0.0250
75 EYELID INFECTION 11 0.0249
76 EYE ALLERGY 38 0.0245
77 MEIBOMIAN GLAND DYSFUNCTION 11 0.0243
78 INTRAOCULAR LENS IMPLANT 12 0.0242
79 CONJUNCTIVAL HYPERAEMIA 84 0.0235
80 HORDEOLUM 101 0.0233
81 PRODUCT DELIVERY MECHANISM ISSUE 125 0.0232
82 IRITIS 68 0.0223
83 CORNEAL EROSION 12 0.0223
84 HYPHAEMA 11 0.0211
85 SUPERFICIAL INJURY OF EYE 23 0.0210
86 FOREIGN BODY IN EYE 20 0.0209
87 HYPOAESTHESIA EYE 12 0.0203
88 CYSTOID MACULAR OEDEMA 38 0.0201
89 EYE LASER SURGERY 11 0.0186
90 PUNCTATE KERATITIS 17 0.0185
91 OCULAR DISCOMFORT 200 0.0178
92 EYE SWELLING 658 0.0177
93 GLAUCOMA 339 0.0176
94 GLARE 9 0.0175
95 EYE PAIN 974 0.0172
96 PRODUCT CONTAINER ISSUE 144 0.0168
97 EYE BURNS 9 0.0153
98 ASTHENOPIA 79 0.0144
99 PERIORBITAL PAIN 12 0.0142
100 DRUG ADMINISTERED AT INAPPROPRIATE SITE 148 0.0140
101 CARDIOACTIVE DRUG LEVEL INCREASED 18 0.0137
102 OCULAR HYPERTENSION 26 0.0134
103 OCULAR VASCULAR DISORDER 11 0.0133
104 DRY EYE 664 0.0133
105 CORNEAL ABRASION 18 0.0131
106 OPTIC NERVE INJURY 15 0.0129
107 LACRIMATION INCREASED 377 0.0125
108 INSTILLATION SITE PAIN 30 0.0121
109 EYE INFLAMMATION 115 0.0120
110 ULCERATIVE KERATITIS 32 0.0117
111 EYE INFECTION 129 0.0114
112 CHOROIDAL EFFUSION 9 0.0112
113 WRONG TECHNIQUE IN DRUG USAGE PROCESS 404 0.0111
114 CORNEAL DISORDER 24 0.0109
115 CONJUNCTIVITIS ALLERGIC 16 0.0108
116 HYPERAEMIA 21 0.0106
117 HALO VISION 12 0.0106
118 EYE OPERATION 48 0.0104
119 EXCESSIVE EYE BLINKING 15 0.0101
120 DACRYOSTENOSIS ACQUIRED 13 0.0101
121 PRODUCT CONTAINER SEAL ISSUE 17 0.0098
122 PHOTOPHOBIA 180 0.0096
123 VISUAL FIELD DEFECT 66 0.0091
124 HERPES OPHTHALMIC 12 0.0091
125 KERATITIS 27 0.0089
126 VISUAL ACUITY REDUCED 285 0.0086
127 PERIORBITAL SWELLING 48 0.0085
128 RETINAL VEIN OCCLUSION 23 0.0080
129 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 539 0.0076
130 ANGLE CLOSURE GLAUCOMA 19 0.0074
131 VITREOUS DETACHMENT 16 0.0074
132 MACULAR OEDEMA 41 0.0073
133 BLEPHAROSPASM 46 0.0073
134 EYE DISORDER 228 0.0069
135 NEPHROGENIC ANAEMIA 32 0.0069
136 OPTIC NERVE DISORDER 11 0.0069
137 EYELID PTOSIS 66 0.0065
138 RETINAL TEAR 16 0.0065
139 BLINDNESS UNILATERAL 91 0.0064
140 SKIN DISCOLOURATION 296 0.0064
141 SKIN WRINKLING 17 0.0062
142 INCORRECT DOSE ADMINISTERED BY PRODUCT 10 0.0062
143 VISION BLURRED 851 0.0062
144 APPLICATION SITE DISCOLOURATION 25 0.0061
145 CATARACT OPERATION 36 0.0061
146 CONJUNCTIVITIS 112 0.0060
147 CATARACT 352 0.0059
148 PRODUCT LOT NUMBER ISSUE 13 0.0059
149 BODY HEIGHT DECREASED 62 0.0058
150 RETINAL DISORDER 15 0.0058
151 VITREOUS FLOATERS 56 0.0057
152 PIGMENTATION DISORDER 35 0.0057
153 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 102 0.0056
154 MIGRAINE WITH AURA 15 0.0055
155 VITREOUS HAEMORRHAGE 15 0.0054
156 EYE INJURY 16 0.0053
157 EYE CONTUSION 11 0.0052
158 HYPERPARATHYROIDISM SECONDARY 13 0.0052
159 IRIDOCYCLITIS 16 0.0051
160 DIABETIC RETINOPATHY 17 0.0050
161 THERAPEUTIC RESPONSE DECREASED 301 0.0050
162 EYE OEDEMA 12 0.0049
163 AORTIC STENOSIS 17 0.0049
164 EYE HAEMORRHAGE 65 0.0049
165 HYPERTRICHOSIS 9 0.0049
166 PHOTOPSIA 30 0.0047
167 EXPIRED PRODUCT ADMINISTERED 157 0.0047
168 PRODUCT PHYSICAL CONSISTENCY ISSUE 26 0.0047
169 HYPERSENSITIVITY 860 0.0046
170 BLINDNESS TRANSIENT 34 0.0046
171 ENDOPHTHALMITIS 27 0.0045
172 RETINAL DETACHMENT 41 0.0045
173 METABOLIC ENCEPHALOPATHY 13 0.0043
174 PRODUCT CONTAMINATION PHYSICAL 11 0.0043
175 UVEITIS 57 0.0042
176 CONJUNCTIVAL HAEMORRHAGE 16 0.0042
177 BLINDNESS 169 0.0041
178 STARING 10 0.0041
179 HAIR DISORDER 33 0.0040
180 PRODUCT PACKAGING ISSUE 38 0.0040
181 LYMPHOCYTE COUNT INCREASED 13 0.0040
182 PARANASAL SINUS HYPERSECRETION 15 0.0039
183 MACULAR DEGENERATION 46 0.0038
184 EXPIRED DRUG ADMINISTERED 19 0.0038
185 VISUAL IMPAIRMENT 474 0.0038
186 FACIAL PARESIS 13 0.0037
187 BLOOD PRESSURE SYSTOLIC ABNORMAL 9 0.0036
188 PRODUCT USE COMPLAINT 56 0.0036
189 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
190 AORTIC ARTERIOSCLEROSIS 9 0.0035
191 ACTINIC KERATOSIS 9 0.0035
192 DYSPNOEA AT REST 10 0.0034
193 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 21 0.0034
194 PRODUCT LABEL ISSUE 23 0.0034
195 RETINAL HAEMORRHAGE 24 0.0034
196 VIRAL UPPER RESPIRATORY TRACT INFECTION 16 0.0034
197 HAIR TEXTURE ABNORMAL 45 0.0034
198 SKIN TIGHTNESS 15 0.0032
199 DRUG INEFFECTIVE 4126 0.0031
200 ACCIDENTAL EXPOSURE 13 0.0031
201 HYPERTONIC BLADDER 9 0.0031
202 PRODUCT CONTAMINATION 11 0.0031
203 INCORRECT DOSAGE ADMINISTERED 15 0.0031
204 EXTRASYSTOLES 21 0.0030
205 HAEMORRHAGIC ANAEMIA 13 0.0030
206 DIPLOPIA 76 0.0029
207 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 590 0.0029
208 DIVERTICULUM 20 0.0028
209 OCULAR ICTERUS 12 0.0028
210 SPINAL COLUMN STENOSIS 13 0.0027
211 HAIR COLOUR CHANGES 34 0.0027
212 DERMATITIS CONTACT 31 0.0027
213 FAILURE TO THRIVE 14 0.0027
214 GOITRE 11 0.0027
215 MULTIPLE USE OF SINGLE-USE PRODUCT 15 0.0027
216 AORTIC VALVE INCOMPETENCE 11 0.0026
217 CAROTID ARTERY STENOSIS 9 0.0026
218 FACIAL PAIN 23 0.0026
219 DYSLIPIDAEMIA 13 0.0026
220 HYPERKERATOSIS 14 0.0025
221 MACULOPATHY 9 0.0025
222 ERYTHEMA 518 0.0025
223 CARDIAC PACEMAKER INSERTION 15 0.0025
224 BLOOD PRESSURE SYSTOLIC INCREASED 49 0.0025
225 PERIORBITAL OEDEMA 13 0.0025
226 INTRACRANIAL ANEURYSM 10 0.0025
227 PRODUCT COMPLAINT 63 0.0025
228 SQUAMOUS CELL CARCINOMA OF SKIN 15 0.0025
229 DRUG ADMINISTRATION ERROR 76 0.0025
230 ACCIDENTAL EXPOSURE TO PRODUCT 255 0.0025
231 ASTHMATIC CRISIS 9 0.0025
232 UPPER-AIRWAY COUGH SYNDROME 20 0.0024
233 PRODUCT FORMULATION ISSUE 16 0.0024
234 SEASONAL ALLERGY 34 0.0024
235 BUNDLE BRANCH BLOCK RIGHT 11 0.0024
236 DRY THROAT 24 0.0024
237 ABSCESS LIMB 10 0.0023
238 EYE MOVEMENT DISORDER 16 0.0023
239 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
240 ECCHYMOSIS 16 0.0023
241 PERIPHERAL VASCULAR DISORDER 12 0.0023
242 SKIN LACERATION 25 0.0023
243 APPLICATION SITE PRURITUS 52 0.0023
244 AZOTAEMIA 9 0.0023
245 WRIST FRACTURE 27 0.0023
246 APPLICATION SITE ERYTHEMA 59 0.0022
247 BLOOD PRESSURE FLUCTUATION 54 0.0022
248 RHINITIS ALLERGIC 10 0.0022
249 SKIN IRRITATION 102 0.0022
250 HEART RATE IRREGULAR 50 0.0022
251 HYPERNATRAEMIA 11 0.0022
252 INCORRECT DOSE ADMINISTERED 502 0.0022
253 POOR QUALITY PRODUCT ADMINISTERED 23 0.0022
254 APPLICATION SITE PAIN 48 0.0022
255 HAEMOGLOBIN ABNORMAL 14 0.0022
256 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
257 ROSACEA 10 0.0021
258 PRODUCT COLOUR ISSUE 11 0.0021
259 INGUINAL HERNIA 13 0.0021
260 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
261 SINUS DISORDER 42 0.0021
262 WRONG PRODUCT ADMINISTERED 14 0.0021
263 BURNING SENSATION 145 0.0021
264 NOCTURIA 25 0.0021
265 MELANOCYTIC NAEVUS 9 0.0021
266 BLOOD CALCIUM INCREASED 18 0.0021
267 CARDIOMEGALY 25 0.0020
268 BREATH SOUNDS ABNORMAL 10 0.0020
269 TRICUSPID VALVE INCOMPETENCE 16 0.0020
270 APPLICATION SITE IRRITATION 25 0.0020
271 APPLICATION SITE SWELLING 10 0.0020
272 PRODUCT ODOUR ABNORMAL 21 0.0020
273 SPUTUM DISCOLOURED 19 0.0020
274 PRODUCT LEAKAGE 11 0.0020
275 DIZZINESS POSTURAL 19 0.0020
276 MUSCLE TWITCHING 45 0.0020
277 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
278 PERONEAL NERVE PALSY 11 0.0019
279 GROIN PAIN 17 0.0019
280 SCAB 22 0.0019
281 HYPERLIPIDAEMIA 23 0.0019
282 LIQUID PRODUCT PHYSICAL ISSUE 14 0.0019
283 END STAGE RENAL DISEASE 35 0.0019
284 SKIN ATROPHY 11 0.0019
285 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 343 0.0019
286 MEDICATION RESIDUE PRESENT 9 0.0019
287 HYPOVOLAEMIA 11 0.0019
288 MYDRIASIS 24 0.0019
289 DERMATITIS 39 0.0019
290 PAROSMIA 14 0.0019
291 PRODUCT RESIDUE PRESENT 10 0.0019
292 DUODENAL ULCER 13 0.0018
293 PRODUCT QUALITY ISSUE 250 0.0018
294 NONSPECIFIC REACTION 10 0.0018
295 RENAL FAILURE CHRONIC 14 0.0018
296 DIABETIC NEUROPATHY 9 0.0018
297 HEAD DISCOMFORT 32 0.0018
298 EAR PAIN 35 0.0018
299 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
300 GOUT 32 0.0018
301 SLUGGISHNESS 18 0.0018
302 DEMENTIA 49 0.0018
303 EXOSTOSIS 16 0.0018
304 ONYCHOCLASIS 12 0.0017
305 DRY MOUTH 141 0.0017
306 HEART RATE DECREASED 61 0.0017
307 STENT PLACEMENT 14 0.0017
308 LYMPHOEDEMA 12 0.0017
309 SKIN WARM 10 0.0017
310 FLUID OVERLOAD 25 0.0017
311 RHINORRHOEA 110 0.0017
312 PHOTOSENSITIVITY REACTION 28 0.0017
313 HAND FRACTURE 12 0.0017
314 NEUTROPENIC SEPSIS 12 0.0017
315 OSTEOARTHRITIS 71 0.0017
316 GINGIVITIS 9 0.0017
317 HEARING IMPAIRED 10 0.0017
318 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
319 COMPLICATION OF DEVICE INSERTION 33 0.0017
320 ELECTROCARDIOGRAM ABNORMAL 13 0.0017
321 OSTEOMYELITIS 30 0.0017
322 CARDIAC FAILURE ACUTE 11 0.0016
323 DRUG DOSE OMISSION 272 0.0016
324 FAECALOMA 9 0.0016
325 VITAMIN D DEFICIENCY 16 0.0016
326 SPLENOMEGALY 19 0.0016
327 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
328 HOSPICE CARE 16 0.0016
329 NECROSIS 9 0.0016
330 PLATELET COUNT INCREASED 21 0.0016
331 ORTHOSTATIC HYPOTENSION 28 0.0016
332 SUBDURAL HAEMATOMA 23 0.0016
333 THROAT IRRITATION 72 0.0016
334 NAIL DISORDER 14 0.0016
335 SECRETION DISCHARGE 20 0.0016
336 PROSTATIC SPECIFIC ANTIGEN INCREASED 22 0.0016
337 NASAL DRYNESS 10 0.0016
338 LACERATION 15 0.0016
339 HYPERTRANSAMINASAEMIA 11 0.0016
340 PRODUCT STORAGE ERROR 138 0.0016
341 CARDIAC VALVE DISEASE 9 0.0016
342 ATRIAL FIBRILLATION 153 0.0016
343 WRONG DRUG ADMINISTERED 14 0.0016
344 HALLUCINATION, VISUAL 33 0.0016
345 NEUTROPHIL COUNT INCREASED 16 0.0016
346 MOUTH SWELLING 9 0.0016
347 ACUTE RESPIRATORY FAILURE 30 0.0016
348 VERTIGO 95 0.0016
349 DYSGEUSIA 115 0.0015
350 SMALL INTESTINAL OBSTRUCTION 19 0.0015
351 PRODUCT ADMINISTRATION ERROR 31 0.0015
352 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
353 SCRATCH 16 0.0015
354 IRON DEFICIENCY ANAEMIA 14 0.0015
355 PRODUCT DISPENSING ERROR 33 0.0015
356 INCONTINENCE 16 0.0015
357 BLADDER DISORDER 15 0.0015
358 RIB FRACTURE 31 0.0015
359 BLOOD MAGNESIUM DECREASED 13 0.0015
360 SCIATICA 24 0.0015
361 ATRIAL FLUTTER 12 0.0015
362 MITRAL VALVE INCOMPETENCE 17 0.0015
363 MELAENA 33 0.0015
364 PULMONARY HYPERTENSION 31 0.0015
365 URINE OUTPUT DECREASED 13 0.0015
366 BLOOD SODIUM DECREASED 28 0.0015
367 AGEUSIA 37 0.0015
368 CARDIAC FAILURE CONGESTIVE 119 0.0015
369 PULMONARY MASS 22 0.0015
370 SNEEZING 33 0.0015
371 BRADYCARDIA 78 0.0015
372 SLEEP APNOEA SYNDROME 28 0.0015
373 MENISCUS INJURY 9 0.0015
374 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
375 UPPER LIMB FRACTURE 29 0.0015
376 HEAD INJURY 46 0.0015
377 DYSPHONIA 85 0.0015
378 ECONOMIC PROBLEM 22 0.0015
379 ATELECTASIS 14 0.0014
380 JOINT STIFFNESS 38 0.0014
381 SINUS BRADYCARDIA 14 0.0014
382 FALL 482 0.0014
383 BLOOD IRON DECREASED 17 0.0014
384 INFUSION SITE SWELLING 9 0.0014
385 INFUSION SITE ERYTHEMA 12 0.0014
386 CONCUSSION 11 0.0014
387 PELVIC FRACTURE 11 0.0014
388 BASAL CELL CARCINOMA 22 0.0014
389 SINUS CONGESTION 19 0.0014
390 THERAPEUTIC RESPONSE UNEXPECTED 63 0.0014
391 HYPOTONIA 14 0.0014
392 ROTATOR CUFF SYNDROME 18 0.0014
393 ERUCTATION 27 0.0014
394 CHRONIC KIDNEY DISEASE 106 0.0014
395 TRANSIENT ISCHAEMIC ATTACK 47 0.0014
396 PSYCHOLOGICAL TRAUMA 12 0.0014
397 NASAL DISCOMFORT 11 0.0014
398 GINGIVAL PAIN 11 0.0014
399 BLOOD PRESSURE INCREASED 211 0.0014
400 NASAL CONGESTION 81 0.0014
401 EPISTAXIS 103 0.0014
402 MIOSIS 11 0.0014
403 ORAL DISORDER 10 0.0014
404 TOOTH FRACTURE 15 0.0014
405 CARPAL TUNNEL SYNDROME 19 0.0014
406 SENSITIVE SKIN 10 0.0014
407 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
408 PLEURAL EFFUSION 82 0.0013
409 SPINAL FRACTURE 27 0.0013
410 HYPOKALAEMIA 62 0.0013
411 ABNORMAL FAECES 11 0.0013
412 HIP FRACTURE 43 0.0013
413 INFLAMMATION 69 0.0013
414 ANAL INCONTINENCE 12 0.0013
415 HALLUCINATION 100 0.0013
416 IMPAIRED QUALITY OF LIFE 19 0.0013
417 BODY TEMPERATURE DECREASED 13 0.0013
418 HYPERGLYCAEMIA 48 0.0013
419 CORONARY ARTERY OCCLUSION 18 0.0013
420 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
421 BLOOD PRESSURE ABNORMAL 26 0.0013
422 BALANCE DISORDER 113 0.0013
423 IRRITABLE BOWEL SYNDROME 28 0.0013
424 SWELLING FACE 85 0.0013
425 PRODUCT DOSE OMISSION ISSUE 383 0.0013
426 SPINAL OPERATION 16 0.0013
427 TENDON RUPTURE 16 0.0013
428 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
429 MASS 18 0.0013
430 HYPERKALAEMIA 45 0.0013
431 BLISTER 72 0.0013
432 HAEMORRHOIDS 25 0.0013
433 PARANOIA 22 0.0013
434 MULTIPLE ALLERGIES 10 0.0013
435 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
436 THERAPEUTIC PRODUCT EFFECT DECREASED 57 0.0013
437 DERMATITIS ALLERGIC 16 0.0013
438 GASTROINTESTINAL HAEMORRHAGE 106 0.0013
439 INITIAL INSOMNIA 13 0.0013
440 WHEEZING 75 0.0013
441 FOOT DEFORMITY 14 0.0013
442 RESPIRATORY TRACT CONGESTION 20 0.0013
443 PRODUCTIVE COUGH 60 0.0013
444 CYSTITIS 40 0.0013
445 HYPERSOMNIA 36 0.0013
446 CARDIOGENIC SHOCK 18 0.0013
447 HYPOACUSIS 54 0.0013
448 BLOOD UREA INCREASED 21 0.0013
449 BLOOD PRESSURE DECREASED 83 0.0012
450 URINARY INCONTINENCE 37 0.0012
451 POLLAKIURIA 52 0.0012
452 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65 0.0012
453 TINNITUS 57 0.0012
454 FULL BLOOD COUNT DECREASED 25 0.0012
455 RHINITIS 10 0.0012
456 FAECES SOFT 9 0.0012
457 SKIN EXFOLIATION 104 0.0012
458 IMPAIRED DRIVING ABILITY 14 0.0012
459 INTENTIONAL DOSE OMISSION 35 0.0012
460 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
461 DECUBITUS ULCER 10 0.0012
462 TENDONITIS 19 0.0012
463 DIVERTICULITIS 34 0.0012
464 RENAL PAIN 13 0.0012
465 NO ADVERSE EVENT 222 0.0012
466 OEDEMA PERIPHERAL 149 0.0012
467 DYSPNOEA EXERTIONAL 46 0.0012
468 INCORRECT PRODUCT STORAGE 16 0.0012
469 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
470 CEREBRAL DISORDER 9 0.0012
471 OPTIC NEURITIS 11 0.0012
472 ASTHENIA 453 0.0012
473 BRONCHITIS 89 0.0012
474 BACK INJURY 13 0.0012
475 PRESYNCOPE 29 0.0012
476 RED BLOOD CELL COUNT DECREASED 34 0.0012
477 SWOLLEN TONGUE 37 0.0012
478 TASTE DISORDER 24 0.0012
479 PRODUCT DOSE OMISSION 77 0.0012
480 PARAESTHESIA ORAL 17 0.0012
481 MIDDLE INSOMNIA 22 0.0012
482 INTERSTITIAL LUNG DISEASE 57 0.0012
483 BOWEL MOVEMENT IRREGULARITY 9 0.0012
484 CELLULITIS 59 0.0012
485 VITAMIN D DECREASED 10 0.0012
486 EAR DISCOMFORT 12 0.0012
487 CARDIAC OPERATION 10 0.0012
488 NECK PAIN 65 0.0012
489 UNRESPONSIVE TO STIMULI 30 0.0012
490 HIATUS HERNIA 15 0.0012
491 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
492 VENTRICULAR EXTRASYSTOLES 12 0.0012
493 PRURITUS 444 0.0012
494 FAECES DISCOLOURED 25 0.0012
495 DEAFNESS 30 0.0011
496 HYPERTENSION 243 0.0011
497 WEIGHT FLUCTUATION 12 0.0011
498 TRANSFUSION 12 0.0011
499 ARTHRITIS 90 0.0011
500 HYPONATRAEMIA 64 0.0011
501 SKIN REACTION 16 0.0011
502 MUSCULAR WEAKNESS 129 0.0011
503 BLOOD ALBUMIN DECREASED 9 0.0011
504 SLEEP DISORDER 80 0.0011
505 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
506 OBESITY 18 0.0011
507 HEPATIC STEATOSIS 21 0.0011
508 OEDEMA 61 0.0011
509 BRONCHOSPASM 16 0.0011
510 OSTEOPENIA 17 0.0011
511 GASTROOESOPHAGEAL REFLUX DISEASE 90 0.0011
512 SKIN CANCER 24 0.0011
513 MYASTHENIA GRAVIS 9 0.0011
514 SINUSITIS 114 0.0011
515 DRUG DISPENSING ERROR 17 0.0011
516 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 61 0.0011
517 INABILITY TO AFFORD MEDICATION 11 0.0011
518 HEADACHE 694 0.0011
519 OROPHARYNGEAL PAIN 102 0.0011
520 BONE DISORDER 20 0.0011
521 IMPAIRED HEALING 36 0.0011
522 HYPOTHYROIDISM 35 0.0011
523 DELUSION 17 0.0011
524 KNEE ARTHROPLASTY 23 0.0011
525 CHOLECYSTITIS 13 0.0011
526 CONTUSION 105 0.0011
527 LOCAL SWELLING 19 0.0011
528 URINARY TRACT INFECTION 185 0.0011
529 DIABETIC KETOACIDOSIS 26 0.0011
530 DIZZINESS 539 0.0011
531 COAGULOPATHY 18 0.0011
532 HERPES ZOSTER 62 0.0011
533 LETHARGY 62 0.0011
534 BURSITIS 13 0.0011
535 NEPHROPATHY 10 0.0011
536 PERIPHERAL SWELLING 165 0.0011
537 KIDNEY INFECTION 21 0.0011
538 CANDIDA INFECTION 18 0.0011
539 NEEDLE ISSUE 31 0.0011
540 THERAPY INTERRUPTED 76 0.0011
541 POOR VENOUS ACCESS 11 0.0011
542 CYTOPENIA 13 0.0011
543 DEVICE DISLOCATION 46 0.0011
544 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
545 CHEST DISCOMFORT 108 0.0011
546 ASTHMA 119 0.0011
547 HAEMATURIA 36 0.0011
548 MUSCULOSKELETAL DISORDER 20 0.0010
549 CYST 13 0.0010
550 PRODUCT PHYSICAL ISSUE 21 0.0010
551 SURGERY 61 0.0010
552 FULL BLOOD COUNT ABNORMAL 11 0.0010
553 TOOTH DISORDER 23 0.0010
554 LIMB DISCOMFORT 32 0.0010
555 MUSCULOSKELETAL CHEST PAIN 16 0.0010
556 JOINT INJURY 22 0.0010
557 RASH MACULAR 36 0.0010
558 GAIT DISTURBANCE 197 0.0010
559 PNEUMONITIS 28 0.0010
560 DEHYDRATION 137 0.0010
561 HAEMOGLOBIN DECREASED 105 0.0010
562 SYNCOPE 102 0.0010
563 ARRHYTHMIA 48 0.0010
564 ACUTE KIDNEY INJURY 155 0.0010
565 SPEECH DISORDER 53 0.0010
566 PULMONARY THROMBOSIS 11 0.0010
567 INFUSION SITE PAIN 13 0.0010
568 CONFUSIONAL STATE 163 0.0010
569 OESOPHAGITIS 11 0.0010
570 ANAEMIA 192 0.0010
571 SKIN ULCER 26 0.0010
572 HYPOCALCAEMIA 19 0.0010
573 MYOSITIS 9 0.0010
574 FLUID RETENTION 51 0.0010
575 LIVER FUNCTION TEST ABNORMAL 29 0.0010
576 GASTROENTERITIS VIRAL 18 0.0010
577 SENSORY DISTURBANCE 16 0.0010
578 DRY SKIN 133 0.0010
579 COUGH 278 0.0010
580 EMPHYSEMA 10 0.0010
581 TOOTH INFECTION 13 0.0010
582 DYSPNOEA 558 0.0010
583 DIABETES MELLITUS 75 0.0010
584 ORAL PAIN 22 0.0010
585 TOOTH ABSCESS 10 0.0010
586 PALPITATIONS 115 0.0010
587 SUBARACHNOID HAEMORRHAGE 10 0.0010
588 OXYGEN SATURATION DECREASED 55 0.0010
589 DYSURIA 36 0.0010
590 WEIGHT DECREASED 273 0.0010
591 MENTAL STATUS CHANGES 27 0.0010
592 TEMPERATURE INTOLERANCE 10 0.0010
593 HAEMOPTYSIS 27 0.0010
594 RENAL FAILURE ACUTE 41 0.0010
595 TOOTH EXTRACTION 12 0.0010
596 HYPOTENSION 193 0.0010
597 INTENTIONAL PRODUCT MISUSE 84 0.0010
598 NERVOUSNESS 50 0.0010
599 ARTERIOSCLEROSIS 9 0.0010
600 CONSTIPATION 208 0.0010
601 INSOMNIA 254 0.0010
602 PAIN IN JAW 27 0.0010
603 FLATULENCE 54 0.0010
604 BLOOD CHOLESTEROL INCREASED 44 0.0009
605 EAR INFECTION 25 0.0009
606 FATIGUE 731 0.0009
607 HYPOPHAGIA 24 0.0009
608 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
609 ARTHROPATHY 52 0.0009
610 ORAL DISCOMFORT 13 0.0009
611 MYALGIA 159 0.0009
612 FLUSHING 95 0.0009
613 PAIN IN EXTREMITY 275 0.0009
614 APHONIA 13 0.0009
615 BLOOD POTASSIUM DECREASED 28 0.0009
616 LIP SWELLING 31 0.0009
617 ABASIA 23 0.0009
618 UPPER RESPIRATORY TRACT INFECTION 43 0.0009
619 ABDOMINAL DISCOMFORT 156 0.0009
620 HYPOAESTHESIA ORAL 14 0.0009
621 HYPOGLYCAEMIA 45 0.0009
622 MUSCULOSKELETAL STIFFNESS 81 0.0009
623 HAEMATOCHEZIA 51 0.0009
624 BLOOD COUNT ABNORMAL 14 0.0009
625 RASH PRURITIC 50 0.0009
626 BACK DISORDER 15 0.0009
627 RESPIRATORY TRACT INFECTION 24 0.0009
628 SKIN FISSURES 18 0.0009
629 BIPOLAR DISORDER 10 0.0009
630 INSURANCE ISSUE 14 0.0009
631 KNEE OPERATION 9 0.0009
632 CHOLELITHIASIS 30 0.0009
633 HIP ARTHROPLASTY 14 0.0009
634 PNEUMONIA 295 0.0009
635 DISABILITY 18 0.0009
636 SARS-COV-2 TEST POSITIVE 12 0.0009
637 HAEMATOCRIT DECREASED 18 0.0009
638 MENTAL IMPAIRMENT 22 0.0009
639 ANKLE FRACTURE 14 0.0009
640 DECREASED APPETITE 210 0.0009
641 GASTRIC DISORDER 31 0.0009
642 OSTEOPOROSIS 37 0.0009
643 CEREBROVASCULAR ACCIDENT 152 0.0009
644 FOOT FRACTURE 17 0.0009
645 NIGHTMARE 31 0.0009
646 HYPERCALCAEMIA 11 0.0009
647 PARAESTHESIA 140 0.0009
648 THROAT TIGHTNESS 24 0.0009
649 SWELLING 83 0.0009
650 PNEUMOTHORAX 14 0.0009
651 PRURITUS GENERALISED 19 0.0009
652 INTERNAL HAEMORRHAGE 10 0.0009
653 PERIPHERAL COLDNESS 12 0.0009
654 DEPRESSED MOOD 46 0.0009
655 ADVERSE DRUG REACTION 78 0.0009
656 MUSCLE ATROPHY 11 0.0009
657 HAEMATEMESIS 22 0.0009
658 BACK PAIN 201 0.0009
659 PERICARDIAL EFFUSION 20 0.0009
660 MUSCLE TIGHTNESS 14 0.0009
661 NEUROPATHY PERIPHERAL 82 0.0009
662 FEELING COLD 24 0.0009
663 RECTAL HAEMORRHAGE 37 0.0009
664 MUSCULOSKELETAL PAIN 45 0.0009
665 CORONARY ARTERY DISEASE 26 0.0009
666 RENAL FAILURE 114 0.0009
667 DEVICE USE ISSUE 15 0.0009
668 CARDIAC DISORDER 80 0.0009
669 DISCOMFORT 52 0.0009
670 ASCITES 25 0.0008
671 PULMONARY OEDEMA 38 0.0008
672 OFF LABEL USE 741 0.0008
673 BLOOD URINE PRESENT 16 0.0008
674 PNEUMONIA ASPIRATION 21 0.0008
675 PRODUCT PRESCRIBING ERROR 20 0.0008
676 FEMUR FRACTURE 26 0.0008
677 SKIN DISORDER 28 0.0008
678 CEREBRAL HAEMORRHAGE 30 0.0008
679 ANGINA PECTORIS 24 0.0008
680 RASH 365 0.0008
681 LUNG DISORDER 41 0.0008
682 POST PROCEDURAL COMPLICATION 16 0.0008
683 CHEST PAIN 154 0.0008
684 NASOPHARYNGITIS 153 0.0008
685 AMNESIA 54 0.0008
686 MEMORY IMPAIRMENT 114 0.0008
687 ANOSMIA 12 0.0008
688 LOCALISED INFECTION 20 0.0008
689 RESTLESS LEGS SYNDROME 15 0.0008
690 ADVERSE EVENT 76 0.0008
691 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
692 THROMBOSIS 66 0.0008
693 QUALITY OF LIFE DECREASED 11 0.0008
694 INJECTION SITE NODULE 9 0.0008
695 PRODUCT SUBSTITUTION ISSUE 47 0.0008
696 ACUTE MYOCARDIAL INFARCTION 24 0.0008
697 OSTEONECROSIS OF JAW 20 0.0008
698 RENAL INJURY 24 0.0008
699 DIARRHOEA 521 0.0008
700 NEPHROLITHIASIS 37 0.0008
701 MIGRAINE 77 0.0008
702 GINGIVAL BLEEDING 11 0.0008
703 BLOOD POTASSIUM INCREASED 13 0.0008
704 SOMNOLENCE 161 0.0008
705 GASTRITIS 21 0.0008
706 CHROMATURIA 18 0.0008
707 DRUG INTOLERANCE 77 0.0008
708 ABDOMINAL DISTENSION 83 0.0008
709 APHASIA 24 0.0008
710 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
711 GLYCOSYLATED HAEMOGLOBIN INCREASED 20 0.0008
712 HYPOMAGNESAEMIA 11 0.0008
713 HUNGER 11 0.0008
714 POOR QUALITY SLEEP 17 0.0008
715 INFLUENZA 88 0.0008
716 FEEDING DISORDER 16 0.0008
717 ROAD TRAFFIC ACCIDENT 33 0.0008
718 STAPHYLOCOCCAL INFECTION 26 0.0008
719 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
720 BLOOD TEST ABNORMAL 11 0.0008
721 PULMONARY FIBROSIS 15 0.0008
722 METASTASES TO LUNG 9 0.0008
723 THYROID DISORDER 12 0.0008
724 TOOTHACHE 14 0.0008
725 LIMB INJURY 21 0.0008
726 BLOOD GLUCOSE INCREASED 145 0.0008
727 CHILLS 90 0.0008
728 FEELING HOT 47 0.0008
729 NODULE 10 0.0008
730 SKIN LESION 21 0.0008
731 CIRCULATORY COLLAPSE 13 0.0008
732 CARDIAC FAILURE 61 0.0008
733 THERAPY CESSATION 39 0.0008
734 SCAR 13 0.0008
735 MOUTH ULCERATION 16 0.0008
736 GLOSSODYNIA 17 0.0008
737 DYSPHAGIA 72 0.0008
738 PULMONARY CONGESTION 10 0.0008
739 BACTERAEMIA 9 0.0008
740 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
741 DISORIENTATION 30 0.0008
742 HEART RATE INCREASED 75 0.0008
743 HOT FLUSH 57 0.0008
744 ADVERSE REACTION 10 0.0008
745 DYSPEPSIA 74 0.0008
746 BLOOD CREATININE INCREASED 49 0.0007
747 BACTERIAL INFECTION 14 0.0007
748 MALAISE 329 0.0007
749 PREGNANCY 15 0.0007
750 MALIGNANT MELANOMA 10 0.0007
751 JOINT RANGE OF MOTION DECREASED 10 0.0007
752 CARDIOMYOPATHY 11 0.0007
753 TREMOR 123 0.0007
754 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 25 0.0007
755 COLITIS 28 0.0007
756 ALOPECIA 145 0.0007
757 LYMPHOCYTE COUNT DECREASED 13 0.0007
758 INTENTIONAL PRODUCT USE ISSUE 64 0.0007
759 MUSCLE SPASMS 134 0.0007
760 LOWER RESPIRATORY TRACT INFECTION 33 0.0007
761 DEEP VEIN THROMBOSIS 47 0.0007
762 FEELING ABNORMAL 173 0.0007
763 MOOD SWINGS 23 0.0007
764 JOINT SWELLING 87 0.0007
765 FUNGAL INFECTION 24 0.0007
766 DYSSTASIA 21 0.0007
767 LEUKOCYTOSIS 13 0.0007
768 DYSARTHRIA 27 0.0007
769 BONE PAIN 42 0.0007
770 DEPRESSION 163 0.0007
771 MOVEMENT DISORDER 23 0.0007
772 PULMONARY EMBOLISM 68 0.0007
773 PHARYNGEAL OEDEMA 11 0.0007
774 RASH ERYTHEMATOUS 34 0.0007
775 RENAL DISORDER 33 0.0007
776 LYMPHOPENIA 10 0.0007
777 HEPATOCELLULAR INJURY 10 0.0007
778 ABDOMINAL PAIN UPPER 145 0.0007
779 FREQUENT BOWEL MOVEMENTS 19 0.0007
780 PRODUCT AVAILABILITY ISSUE 16 0.0007
781 PRESCRIBED UNDERDOSE 14 0.0007
782 ERECTILE DYSFUNCTION 18 0.0007
783 PANCREATITIS 37 0.0007
784 ARTHRALGIA 291 0.0007
785 NEURALGIA 17 0.0007
786 HAEMORRHAGE 73 0.0007
787 MOOD ALTERED 19 0.0007
788 RASH GENERALISED 18 0.0007
789 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
790 VIRAL INFECTION 23 0.0007
791 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
792 INTESTINAL OBSTRUCTION 26 0.0007
793 ABSCESS 11 0.0007
794 ABNORMAL DREAMS 19 0.0007
795 ANHEDONIA 18 0.0007
796 ORAL CANDIDIASIS 9 0.0007
797 NIGHT SWEATS 22 0.0007
798 ANXIETY 194 0.0007
799 ILLNESS 70 0.0007
800 LYMPHADENOPATHY 24 0.0007
801 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
802 DRUG INTERACTION 107 0.0007
803 UNEVALUABLE EVENT 51 0.0007
804 ACNE 51 0.0007
805 LOSS OF CONSCIOUSNESS 86 0.0007
806 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
807 RASH PAPULAR 15 0.0007
808 RESPIRATORY DISORDER 20 0.0007
809 PAIN 410 0.0007
810 PANCREATITIS ACUTE 15 0.0007
811 NAUSEA 527 0.0007
812 MEDICATION ERROR 37 0.0007
813 DRUG EFFECT INCOMPLETE 24 0.0007
814 STOMATITIS 40 0.0007
815 PLATELET COUNT DECREASED 70 0.0007
816 WEIGHT INCREASED 147 0.0007
817 ACCIDENTAL OVERDOSE 24 0.0007
818 APPLICATION SITE RASH 9 0.0007
819 HEMIPARESIS 11 0.0006
820 CONDITION AGGRAVATED 197 0.0006
821 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 31 0.0006
822 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
823 LABORATORY TEST ABNORMAL 19 0.0006
824 LUNG INFECTION 10 0.0006
825 INCORRECT ROUTE OF DRUG ADMINISTRATION 23 0.0006
826 HEPATIC CIRRHOSIS 12 0.0006
827 DIALYSIS 9 0.0006
828 COVID-19 111 0.0006
829 FEELING JITTERY 12 0.0006
830 ULCER 10 0.0006
831 GAIT INABILITY 21 0.0006
832 BLOOD GLUCOSE DECREASED 30 0.0006
833 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
834 HAEMATOMA 16 0.0006
835 GASTROENTERITIS 9 0.0006
836 EMOTIONAL DISORDER 19 0.0006
837 GALLBLADDER DISORDER 11 0.0006
838 PLASMA CELL MYELOMA 24 0.0006
839 CHOKING 12 0.0006
840 DISEASE PROGRESSION 72 0.0006
841 WOUND 17 0.0006
842 LIVER FUNCTION TEST INCREASED 13 0.0006
843 HEPATIC ENZYME INCREASED 41 0.0006
844 SEPSIS 67 0.0006
845 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
846 COGNITIVE DISORDER 28 0.0006
847 URINARY RETENTION 20 0.0006
848 PRODUCT PRESCRIBING ISSUE 13 0.0006
849 HYPOXIA 21 0.0006
850 PRODUCT USE ISSUE 112 0.0006
851 BLOOD GLUCOSE ABNORMAL 11 0.0006
852 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
853 PAIN OF SKIN 16 0.0006
854 ILL-DEFINED DISORDER 36 0.0006
855 VOMITING 278 0.0006
856 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
857 URTICARIA 98 0.0006
858 MYOCARDIAL INFARCTION 102 0.0006
859 DEVICE MALFUNCTION 41 0.0006
860 INFLUENZA LIKE ILLNESS 48 0.0006
861 RHEUMATOID ARTHRITIS 66 0.0006
862 HYPOAESTHESIA 87 0.0006
863 MUSCULOSKELETAL DISCOMFORT 10 0.0006
864 EXPOSURE VIA SKIN CONTACT 15 0.0006
865 PROCEDURAL PAIN 16 0.0006
866 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
867 ABDOMINAL PAIN 134 0.0006
868 RESPIRATORY FAILURE 42 0.0006
869 INCREASED APPETITE 11 0.0006
870 INFECTION 83 0.0006
871 PANCYTOPENIA 32 0.0006
872 DRUG PRESCRIBING ERROR 11 0.0006
873 NEOPLASM MALIGNANT 38 0.0006
874 METASTASES TO LIVER 10 0.0006
875 HERNIA 11 0.0006
876 HYPERHIDROSIS 73 0.0006
877 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
878 DRUG ERUPTION 10 0.0006
879 METABOLIC ACIDOSIS 18 0.0006
880 THIRST 10 0.0006
881 RENAL IMPAIRMENT 47 0.0006
882 ABNORMAL BEHAVIOUR 22 0.0006
883 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
884 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
885 RESPIRATORY DISTRESS 15 0.0005
886 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
887 DYSKINESIA 22 0.0005
888 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
889 LUNG NEOPLASM MALIGNANT 22 0.0005
890 FIBROMYALGIA 13 0.0005
891 GASTRIC ULCER 10 0.0005
892 PRODUCT USE IN UNAPPROVED INDICATION 130 0.0005
893 PYREXIA 181 0.0005
894 CRYING 19 0.0005
895 LOWER LIMB FRACTURE 10 0.0005
896 RESTLESSNESS 19 0.0005
897 BLOOD BILIRUBIN INCREASED 14 0.0005
898 PRESCRIBED OVERDOSE 10 0.0005
899 EATING DISORDER 11 0.0005
900 ECZEMA 27 0.0005
901 TREATMENT NONCOMPLIANCE 28 0.0005
902 MENTAL DISORDER 22 0.0005
903 SKIN BURNING SENSATION 36 0.0005
904 DRUG EFFECT DECREASED 27 0.0005
905 DISTURBANCE IN ATTENTION 27 0.0005
906 HOSPITALISATION 76 0.0005
907 RASH MACULO-PAPULAR 11 0.0005
908 BREAST CANCER 46 0.0005
909 CEREBRAL INFARCTION 12 0.0005
910 INJURY ASSOCIATED WITH DEVICE 10 0.0005
911 DEVICE ISSUE 44 0.0005
912 DELIRIUM 17 0.0005
913 PRODUCT PREPARATION ERROR 10 0.0005
914 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
915 TACHYCARDIA 43 0.0005
916 FEAR 13 0.0005
917 INFUSION RELATED REACTION 32 0.0005
918 GASTROINTESTINAL DISORDER 43 0.0005
919 SHOCK 11 0.0005
920 PALLOR 13 0.0005
921 DEATH 406 0.0005
922 MULTIPLE SCLEROSIS RELAPSE 32 0.0005
923 LACTIC ACIDOSIS 15 0.0005
924 MOBILITY DECREASED 33 0.0005
925 GENERAL PHYSICAL HEALTH DETERIORATION 53 0.0005
926 ALANINE AMINOTRANSFERASE INCREASED 28 0.0005
927 INJURY 32 0.0005
928 FEBRILE NEUTROPENIA 30 0.0005
929 AGITATION 33 0.0004
930 BODY TEMPERATURE INCREASED 9 0.0004
931 ANGIOEDEMA 19 0.0004
932 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
933 THERAPY NON-RESPONDER 19 0.0004
934 IMPAIRED WORK ABILITY 9 0.0004
935 NERVOUS SYSTEM DISORDER 13 0.0004
936 TYPE 2 DIABETES MELLITUS 14 0.0004
937 IRRITABILITY 25 0.0004
938 DEVICE DELIVERY SYSTEM ISSUE 11 0.0004
939 DERMATITIS ATOPIC 21 0.0004
940 SUICIDAL IDEATION 36 0.0004
941 SEPTIC SHOCK 17 0.0004
942 THROMBOCYTOPENIA 43 0.0004
943 UNDERDOSE 28 0.0004
944 COLITIS ULCERATIVE 17 0.0004
945 DISEASE RECURRENCE 18 0.0004
946 COMA 18 0.0004
947 INJECTION SITE BRUISING 30 0.0004
948 PSORIASIS 49 0.0004
949 NEOPLASM PROGRESSION 13 0.0004
950 EXTRA DOSE ADMINISTERED 15 0.0004
951 PSORIATIC ARTHROPATHY 15 0.0004
952 NEUTROPHIL COUNT DECREASED 15 0.0004
953 EMOTIONAL DISTRESS 44 0.0004
954 INJECTION SITE REACTION 25 0.0004
955 PANIC ATTACK 13 0.0004
956 GYNAECOMASTIA 11 0.0004
957 MULTIPLE SCLEROSIS 17 0.0004
958 CARDIAC ARREST 29 0.0004
959 DRUG-INDUCED LIVER INJURY 11 0.0004
960 ANAPHYLACTIC SHOCK 9 0.0003
961 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
962 LIVER DISORDER 15 0.0003
963 INJECTION SITE HAEMORRHAGE 27 0.0003
964 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
965 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
966 C-REACTIVE PROTEIN INCREASED 12 0.0003
967 ANGER 11 0.0003
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
969 AGGRESSION 16 0.0003
970 BONE DENSITY DECREASED 10 0.0003
971 NEUTROPENIA 43 0.0003
972 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
973 CARDIO-RESPIRATORY ARREST 13 0.0003
974 ANAPHYLACTIC REACTION 17 0.0003
975 OSTEONECROSIS 10 0.0003
976 SEIZURE 35 0.0003
977 INJECTION SITE SWELLING 23 0.0003
978 HEPATIC FAILURE 9 0.0003
979 INJECTION SITE PRURITUS 19 0.0003
980 INJECTION SITE ERYTHEMA 35 0.0003
981 CONVULSION 16 0.0003
982 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
983 INJECTION SITE PAIN 80 0.0003
984 LEUKOPENIA 13 0.0003
985 TOXICITY TO VARIOUS AGENTS 41 0.0002
986 INTENTIONAL OVERDOSE 14 0.0002
987 OVERDOSE 47 0.0002
988 DEVICE DIFFICULT TO USE 14 0.0002
989 DEVICE LEAKAGE 9 0.0002
990 PROSTATE CANCER 16 0.0002
991 DRUG WITHDRAWAL SYNDROME 15 0.0002
992 BLADDER CANCER 9 0.0002